REDUCED BLADDER CAPACITY

This adverse event was reported 89 times

REDUCED BLADDER CAPACITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 KETAMINE HYDROCHLORIDE 28 0.0055
1 GEMCITABINE INTRAVESICAL 2 0.0041
2 AMIFOSTINE 1 0.0012
3 NATEGLINIDE 1 0.0007
4 TIOCONAZOLE 1 0.0006
5 SENNOSIDES A AND B 1 0.0006
6 SATRALIZUMAB 1 0.0006
7 GALSULFASE 2 0.0005
8 VELAGLUCERASE ALFA 1 0.0005
9 CABOTEGRAVIR AND RILPIVIRINE 3 0.0005
See all drugs enriched for association with REDUCED BLADDER CAPACITY